芽球増加を伴う不応性貧血
WordNet
- shatter as if by explosion (同)knock down
- shrivel or wither or mature imperfectly
- make with or as if with an explosion; "blast a tunnel through the Alps"
- a very long fly ball
- an explosion (as of dynamite)
- make a strident sound; "She tended to blast when speaking into a microphone" (同)blare
- create by using explosives; "blast a passage through the mountain" (同)shell
- use explosives on; "The enemy has been shelling us all day" (同)shell
- fire a shot; "the gunman blasted away" (同)shoot
- apply a draft or strong wind to to; "the air conditioning was blasting cold air at us"
- more than is needed, desired, or required; "trying to lose excess weight"; "found some extra change lying on the dresser"; "yet another book on heraldry might be thought redundant"; "skills made redundant by technological advance"; "sleeping in the spare room"; "supernumerary ornamentation"; "it was supererogatory of her to gloat"; "delete superfluous (or unnecessary) words"; "extra ribs as well as other supernumerary internal parts"; "surplus cheese distributed to the needy" (同)extra, redundant, spare, supererogatory, superfluous, supernumerary, surplus
- immoderation as a consequence of going beyond sufficient or permitted limits (同)excessiveness, inordinateness
- a quantity much larger than is needed (同)surplus, surplusage, nimiety
- temporarily unresponsive or not fully responsive to nervous or sexual stimuli; "the refractory period of a muscle fiber"
- not responding to treatment; "a stubborn infection"; "a refractory case of acne"; "stubborn rust stains" (同)stubborn
- a message whose ingenuity or verbal skill or incongruity has the power to evoke laughter (同)humor, humour, witticism, wittiness
PrepTutorEJDIC
- 〈C〉(風の)『一吹き』,一陣の風;突風,疾風《+『of』+『名』》 / 〈C〉(穴から吹き出す空気の)一吹き / 〈C〉(笛・らっぱなどの)突然の大きな[不快な]音《+『of』+『名』》 / 〈C〉〈U〉爆破(explosion)《+『of』+『名』》 / 〈C〉(1回分の)発破,爆薬 / 〈C〉〈U〉爆風 / …'を'『爆破する』;…'を'爆破して作る(開く) / 《文》…'を'孫なう,台なしにする;〈霜などが〉…'を'枯 / 〈らっぱなど〉'を'急に大きく鳴らす / …'を'酷評する;(…について)〈人〉'を'こっぴどく叱る《+『名』+『about』+『名』(do『ing』)》 / …'を'のろう(damn)
- 〈U〉《時にan~》(…の…に対する)超過《+『of』+『名』+『over』+『名』》 / 〈U〉(…の)『不節制』《+『at』+『名,』+『in』 do『ing』》;《複数形で》度を超えた行為,不行跡;暴飲,暴食 / 超過の,余分の
- (人などが)手に負えない,強情な / (病気が)治りにくい,がんこな / (金属などが)溶けにくい,耐火性の
- 《随伴・協調》…『と』,と共に,といっしょに / 《所有・所持》…『を持っている』,がある,の付いた / 《道具・手段》…『で』,を使って / 《財料・供給物》…『で』,を与えて / …を支持して,に賛成して / …『に反対(敵対)して』,を相手として / …『と同時に』,と同様に / …『に比べて』,に比例して / 《様態》《名詞を伴い副詞句として》『…で』,を示して,をもって / 《付帯状競》…『して』,しながら / 《譲歩》…がありながら,にもかかわらず / 『…が原因で』,のために,…で / …に任せて,のもとにあずけて,のところに / …に関して,について / …から離れて / 《連結・混合》…と / 《副詞と共に命令文で》
- 知る(know)
- 〈U〉『機知』,機転,ウィット / 〈C〉『機知に富む人』,機転のきく人 / 《複数形で;単数扱い》『理解(表現)力』,知性 / 《複数形で》(物事を見抜いたりもくろんだりする)才覚,才知 / 《複数形で;単数扱い》正気
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/01/23 13:15:11」(JST)
[Wiki en表示]
Refractory anemia with excess of blasts |
Classification and external resources |
ICD-10 |
D46.2 |
ICD-9 |
238.73 |
ICD-O: |
M9983/3 |
MeSH |
D000754 |
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome[1] with a marrow blast percentage of 5% to 19%.[2]
In MeSH, "Smoldering leukemia" is classified under RAEB.[3]
References[edit]
- ^ Palmieri S, D'Arco AM, Celentano M, et al. (July 2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi:10.1093/annonc/mdl083. PMID 16687417.
- ^ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood 90 (8): 2969–77. PMID 9376577.
- ^ Leukemia, Smoldering at the US National Library of Medicine Medical Subject Headings (MeSH)
External links[edit]
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
Myeloid hematological malignancy/leukemia histology (ICD-O 9590–9989, C81–C96, 200–208)
|
|
CFU-GM/
and other granulocytes |
CFU-GM
|
Myelocyte
|
AML: Acute myeloblastic leukemia (M0, M1, M2), APL/M3
MP (Chronic neutrophilic leukemia)
|
|
Monocyte
|
AML (AMoL/M5, Myeloid dendritic cell leukemia)
CML (Philadelphia chromosome, Accelerated phase chronic myelogenous leukemia)
|
|
Myelomonocyte
|
AML (M4)
MD-MP (Juvenile myelomonocytic leukemia, Chronic myelomonocytic leukemia)
|
|
Other
|
Histiocytosis
|
|
|
CFU-Baso
|
AML (Acute basophilic)
|
|
CFU-Eos
|
AML (Acute eosinophilic)
MP (Chronic eosinophilic leukemia/Hypereosinophilic syndrome)
|
|
|
MEP |
CFU-Meg
|
AML (AMKL/M7)
MP (Essential thrombocytosis)
|
|
CFU-E
|
AML (Erythroleukemia/M6)
MP (Polycythemia vera)
MD (Refractory anemia, Refractory anemia with excess of blasts, Chromosome 5q deletion syndrome, Sideroblastic anemia, Paroxysmal nocturnal hemoglobinuria, Refractory cytopenia with multilineage dysplasia)
|
|
|
CFU-Mast |
Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)
Mastocytosis: Diffuse cutaneous mastocytosis · Erythrodermic mastocytosis · Generalized eruption of cutaneous mastocytosis (adult type) · Generalized eruption of cutaneous mastocytosis (childhood type) · Mast cell sarcoma · Solitary mastocytoma · Systemic mastocytosis · Xanthelasmoidal mastocytosis
|
|
Multiple/unknown |
AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia
|
|
|
cell/phys (coag, heme, immu, gran), csfs
|
rbmg/mogr/tumr/hist, sysi/epon, btst
|
drug (B1/2/3+5+6), btst, trns
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
- Courville EL1, Singh C1, Yohe S1, Linden MA1, Naemi K1, Berger M1, Ustun C2, McKenna RW1, Dolan M3.
- American journal of clinical pathology.Am J Clin Pathol.2016 Apr;145(4):459-66. doi: 10.1093/ajcp/aqw024. Epub 2016 Mar 25.
- OBJECTIVES: Isolated deletion (20q) is relatively common in myeloid neoplasms and has been rarely reported in cases of therapy-related myelodysplastic syndrome (MDS). Our aim was to characterize cases of isolated del(20q) in bone marrow biopsy specimens from patients with a history of chemotherapy w
- PMID 27124938
- Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
- Nomdedeu M1,2, Calvo X3, Pereira A1, Carrió A1, Solé F4,5, Luño E6, Cervera J7, Vallespí T8, Muñoz C1, Gómez C1, Arias A1, Such E7, Sanz G7, Grau J5, Insunza A9, Calasanz MJ10, Ardanaz MT11, Hernández-Rivas JM12,13, Azaceta G14, Álvarez S15, Sánchez J16,17, Martín ML18, Bargay J19, Gómez V20, Cervero CJ21, Allegue MJ22, Collado R23, Campo E1, Esteve J1, Nomdedeu B1, Costa D1; Spanish Group of Myelodysplastic Syndromes.
- Genes, chromosomes & cancer.Genes Chromosomes Cancer.2016 Apr;55(4):322-7. doi: 10.1002/gcc.22333. Epub 2015 Dec 22.
- Chromosomal translocations are rare in the myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). With the exception of t(3q), translocations are not explicitly considered in the cytogenetic classification of the IPSS-R and their impact on disease progression and patient surviva
- PMID 26690722
- Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes.
- Ding K1, Fu R1, Liu H1, Nachnani DA1, Shao ZH1.
- Oncology letters.Oncol Lett.2016 Apr;11(4):2347-2352. Epub 2016 Feb 23.
- Thrombocytopenia is a common, often fatal complication experienced by patients with myelodysplastic syndromes (MDS). 5-aza-2'-deoxycytidine (decitabine) has been used to treat MDS patients with thrombocytopenia with a response rate of 45-50%. However, the mechanism of its effects on megakaryocytes r
- PMID 27073478
Japanese Journal
- 多重癌の治療歴があり,<i>MLL</i>遺伝子増幅を認めた急性骨髄性白血病・骨髄異形成症候群の2症例
- 蛋白同化ホルモン, 免疫抑制剤, ビタミンD・Kに反応しない低リスク骨髄異形成症候群に対して, azacitidine を長期継続投与中の高齢男性
- The Level of Bone Marrow WT1 Message is a Useful Marker to Differentiate Myelodysplastic Syndromes with Low Blast Percentage from Cytopenia due to Other Reasons
Related Links
- 6 Jun 2011 ... The 2008 World Health Organization (WHO) classification of myelodysplastic syndromes (MDS) recognized several distinct entities with particular clinical behavior and clinicopathologic features. A number of factors influence ...
Related Pictures
★リンクテーブル★
[★]
芽球増加型不応性貧血、芽球増加を伴う不応性貧血
- 関
- refractory anemia with excess blasts refractory anemia with excess of blasts
[★]
- 英
- refractory anemia with excess blasts、RAEB
- 関
- 芽球増加型不応性貧血
- 英
- refractory anemia with excess of blasts
[★]
- 英
- refractory anemia with excess blasts、RAEB
- 関
- 芽球増加を伴う不応性貧血
[★]
- 手に負えない、御しがたい
- (病気などが)難治性の、抗療性の。(刺激に)不応性の、無反応性の。抵抗性がある、免疫性の(to)
- 関
- intractable、inveterate、recalcitrance、recalcitrant、refractoriness、resistance、resistant、resistive
[★]
- 関
- binge、excessive、excessively、hyper、overly、oversupply、repletion、superfluous、supernumerary、surplus、undue、unduly
[★]
- 関
- -blast、blast cell、blastic、gemmule